Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis

Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis

10.3389/fphar.2018.01294

Saved in:

Bibliographic Details
Main Authors:	Shanmugam, Muthu K, Ahn, Kwang Seok, Hsu, Annie, Woo, Chern Chiuh, Yuan, Yi, Tan, Kwong Huat Benny, Chinnathambi, Arunachalam, Alahmadi, Tahani Awad, Alharbi, Sulaiman Ali, Koh, Angele Pei Fern, Arfuso, Frank, Huang, Ruby Yun-Ju, Lim, Lina HK, Alan, Gautam Sethi, Kumar, Alan Prem
Other Authors:	PHARMACOLOGY
Format:	Article
Language:	English
Published:	FRONTIERS MEDIA SA 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy breast cancer metastasis thymoquinone chemokine receptor 4 preclinical "in vivo" study NF-KAPPA-B CHEMOKINE RECEPTOR CXCR4 HUMAN HEPATOCELLULAR-CARCINOMA EMERGING TARGETED THERAPIES OXIDATIVE STRESS TUMOR-GROWTH TRANSGENIC ADENOCARCINOMA TRANSCRIPTION FACTORS POTENTIAL ROLE MURINE MODELS
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/219262
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Description
Summary:	10.3389/fphar.2018.01294